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The dinucleotide AG, found at the 3' end of virtually all eukaryotic pre-mRNA introns, is thought to be
essential for splicing. Reduction-of-function mutations in two Caenorhabditis ekgans genes, the receptor
tyrosine kinase gene let-23 and the collagen gene dpy-10, both alter the AG at the end of a short (ca. 50-
nucleotide) intron to AA. The in vivo effects of these mutations were studied by sequencing polymerase chain
reaction-amplified reverse-transcribed RNA isolated from the two mutants. As expected, we find transcripts
that splice to a cryptic AG, skip an exon, and retain an unspliced intron. However, we also find significant levels
of splicing at the mutated 3' splice site (AA) and at nearby non-AG dinucleotides. Our results indicate that for
short C. elegans introns an AG is not required for splicing at either the correct 3' splice site or incorrect sites.
Analysis of a splice site mutant involving a longer, 316-nucleotide C. elegans intron indicates that an AG is also
not required there for splicing. We hypothesize that elements besides the invariant AG, e.g., an A-U-rich
region, a UUUC motif, and/or a potential branch point sequence, are directing the selection of the 3' splice site
and that in wild-type genes these elements cooperate so that proper splicing occurs.
The dinucleotide AG is an essential feature of the 3' splice
acceptor site of eukaryotic pre-mRNA introns. A compari-
son of approximately 3,700 pre-mRNA introns from verte-
brates, invertebrates, plants, yeasts, and viruses shows that
the AG at the 3' end of introns is virtually invariant: all
contain the ultimate nucleotide G, and only four exceptions
(involving alternative splice sites) to the penultimate nucle-
otide A were found (27, 50). All the introns of the nematode
Caenorhabditis elegans analyzed to date also end with the
dinucleotide AG (15).
Consistent with its striking conservation, the invariant AG
is functionally critical for proper splicing. Alteration of the
invariant AG to either AA, AU, CG, GG, or UG inhibits
splicing in vitro (1, 35, 45). The importance of the dinucle-
otide AG is also supported by in vivo studies. Introns
harboring point mutations in the AG dinucleotide are abnor-
mally spliced in yeasts (1), Neurospora crassa (34), and
mammalian cells (25, 38). Conversely, mutations that create
an AG (e.g., AC mutated to AG) sometimes result in the
selection of the newly created AG as a new 3' splice site (36,
57).
The necessity of having an AG at the 3' end of introns also
has implications for numerous human disorders. Diseases
associated with point mutation of either the A or the G at the
3' end of an intron include analbuminemia (47), ,-thalasse-
mia (4), citrullinemia (30, 52), cystic fibrosis (21), debriso-
quine polymorphism (22), hemophilia (9), familial type III
hyperlipoproteinemia (10), lipoprotein lipase deficiency (23),
ornithine transcarbamylase deficiency (8), osteogenesis im-
perfecta (58), Tay-Sachs disease (39), and xeroderma pig-
mentosum (49).
The in vivo consequences of altering the AG at a 3' splice
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site vary and generally fall into three classes: cryptic splic-
ing, exon skipping, and a failure to splice. When the AG at
the end of an intron is mutated or deleted, cryptic splicing
can occur at an AG that is not normally used as a 3' splice
site. This cryptic AG is usually, but not always, nearby and
can be located downstream (1, 30, 34, 49, 52) or upstream of
the original 3' splice site (4, 10, 25). On the other hand,
mutation or removal of the AG at the 3' end of an intron can
sometimes result in exon skipping: the 5' end of the mutated
intron is used as the donor splice site, and the 3' end of the
next intron downstream is used as the acceptor splice site
(38, 58). As a result, the mutant intron, the next exon, and
the next intron are all spliced out together. Lastly, an intron
harboring a mutated or deleted AG sometimes remains
unspliced (10, 52).
Here we report on the splicing defects associated with
mutation of the invariant AG to an AA in two short C.
elegans introns: the 53-nucleotide (nt) intron 16 of the let-23
gene and the 48-nt intron 2 of the dpy-10 gene. Both the
number and the nature of the resulting splicing products are
unprecedented. We have also analyzed a double AG to AA
mutation in a longer 316-nt intron of let-23. Our results
indicate that splicing in C. elegans does not require an AG at
the 3' splice site, suggesting that elements other than an AG
can direct the selection and usage of 3' splice sites. We
discuss the implications of these findings to splicing in C.
elegans and other organisms.
MATERIALS AND METHODS
We describe the materials and methods used for the let-23
and dpy-10 investigations separately since the studies were
mostly carried out independently.
Localization of mutations. (i) kt-23(nl045) and let-23
(sy97sy122). The n1O45 mutation was localized and se-
quenced as described for the allele let-23(sy5) (2). The n1045
intron 16 mutation discussed here is most likely the only
626
SPLICING WITHOUT AN AG AT THE 3' SPLICE SITE 627
mutation associated with n1045. The entire let-23(nlO45)
coding sequence and all exon/intron boundaries were exam-
ined multiple times for hydroxylamine polymorphisms, and
only the intron 16 polymorphism was found. Furthermore,
both genomic and cDNA sequence have been generated for
more than 100 bases of either side of the n1045 mutation. No
other mutation has been found. The mutation sy122 was
isolated as an intragenic revertant of the let-23 allele sy97
(27b). The specific alteration associated with this mutant was
found by directly sequencing polymerase chain reaction
(PCR)-amplified genomic DNA.
(ii) dpy-10(e128). The dpy-1O(el28) mutation was localized
by PCR amplification of the entire dpy-10 gene from e128
genomic DNA and subsequent cloning of the products into
pBS (Stratagene). Five independent clones were sequenced
by using standard dideoxy sequencing and Sequenase ver-
sion 2.0 (U.S. Biochemical Corp.).
Preparation of RNA. (i) kt-23(nl045) and ket-23(sy97sy122).
The strain MT2123/PS48 let-23(nlO45) was grown at 20°C on
special nematode growth factor (NGM) plates up to or just
past starvation and was harvested by using standard proto-
cols (53). Nematodes were washed off in EN (0.1 M NaCl,
0.01 M EDTA [pH 7.4]), rinsed twice, cleaned with a sucrose
flotation, and frozen in liquid nitrogen. To extract RNA
(protocol from Paul Kayne and Russell Hill), the pellet was
crushed with a mortar and pestle under liquid nitrogen,
resuspended in 3 ml of GTC (4 M guanidinium thiocyanate,
25 mM sodium citrate [pH 7], 0.5% Sarkosyl), and then
homogenized with a polytron (generator PT-DA 3007/2). The
worm homogenate was layered on top of a CsCl cushion (5.7
M CsCl, 0.1 M EDTA) and centrifuged at 35,000 rpm in an
SW55Ti rotor for 15 h. The RNA pellet was resuspended in
dimethylpyrocarbonate (DEPC)-treated water, precipitated
with LiCl, and resuspended again. RNA from the wild-type
strain (courtesy of Jane Mendel) was similarly extracted,
except the animals were harvested during exponential
growth. RNA from PS463 let-23(sy97sy122) unc-4(e120);
him-S(e1490) newly starved nematodes was isolated by using
the RNAzol B method (Tel-Test, Inc.).
(ii) dpy-10(e128). Liquid cultures of either dpy-1O(el28) or
wild-type worms were grown at 20°C in worm growth media
and OP50 and harvested before starvation (54). These mixed
populations of worms were washed in M9 salts and resus-
pended in 5 volumes of 5 M guanidine isothiocyanate-10 mM
EDTA-50 mM Tris (pH 7.5)-8% P-mercaptoethanol. Worms
were homogenized with a polytron for 2 to 3 min and then
spun at 10,000 rpm for 30 min at 4°C (Beckman JA-20 rotor).
Five volumes of 4 M LiCl were added to the supernatant,
which was then allowed to chill at 4°C overnight and then
spun as described above. The pellet was resuspended in 5 ml
of 3 M LiCl and respun. The pellet was resuspended in 2 ml
of 10 mM Tris (pH 7.5)-i mM EDTA-0.1% sodium dodecyl
sulfate and frozen at -20°C. The mixture was allowed to
thaw while being vortexed. After a phenol-chloroform ex-
traction, 1/15 volume of 3 M sodium acetate and 2 volumes
of ethanol were added to the aqueous phase. RNA was spun
down at 10,000 rpm for 20 min at 4°C and resuspended in 0.6
ml of TE (10 mM Tris [pH 8.0], 1 mM EDTA).
Reverse transcription-PCR analysis. (i) let-23(n1045) and
let-23(sy97sy122). Two micrograms of random hexamers was
added to 31 jig of n1045 or 13 ,ug of wild-type RNA. The
tubes were heated to 70°C for 10 min and then placed on ice.
Reverse transcription buffer (Bethesda Research Laborato-
ries), deoxynucleoside triphosphates (dNTPs) (final concen-
tration, 0.5 mM each), RNasin (80 units; Promega), and
Moloney murine leukemia virus reverse transcriptase (800
units; Bethesda Research Laboratories) were added to a final
volume of 80 ,ul. The reaction mixtures were incubated at
37°C for 1 h. The above reaction mixture (1.5 ,ul) was then
PCR amplified (94°C for 3 min; 30 rounds at 94°C for 1 min,
at 55°C for 30 s, and at 72°C for 1.5 min; and then a 7-min
extension at 72°C after the last round of amplification). The
primers CTS5 (exon 16) and CTS3 (exon 18) were used
unless otherwise stated (location as shown in Fig. 1A; CI'S5
primer sequence: 5'CTCATCTAGGTACAAAACGGAGC
C3'; CTS3 primer sequence: 5'CCAAGCTTGTATGAGA
TGAATGGCAACGG3'). A negative control was always
performed with water as a substitute for the substrate.
Reverse transcription of sy97sy122 RNA and amplification
were similarly performed.
To verify that splicing of upstream introns was occurring
normally in n1045, primers from exons 13 and 15 were used
in PCR amplification (data not shown). Only one band with
the size expected for a wild-type splice was found. Amplifi-
cation was also performed with primers from exons 15 and
17 and with primers from exons 15 and 18. The results
suggested that intron 15 is also correctly spliced out and that
no upstream exon skipping is taking place.
We also performed a control in which reverse tran-
scriptase was left out of the reaction to verify that the n1045
bands are the result of reverse transcription of RNA (data
not shown). Sixty micrograms of DNase-treated RNA was
treated as described above for reverse transcription up to the
addition of enzyme. The reaction mixture was then split into
two tubes. In one tube, 200 units of reverse transcriptase
was added; in the other, DEPC-treated water was added.
The tubes were incubated at 37°C for 1 h and then PCR
amplified. The sample lacking reverse transcriptase pro-
duced no bands upon amplification, whereas the sample
including reverse transcriptase produced all the expected
bands.
(ii) dpy-10(e128). Reverse transcription-PCR analysis was
performed as described previously (28). RNA (5 jig) was
reverse transcribed in lx PCR buffer (50 mM KCl, 20 mM
Tris [pH 8.4], 2.5 mM MgCl2, 0.1 mg of bovine serum
albumin per ml), 2.5 mM deoxynucleotide triphosphate with
200 U of Moloney murine leukemia virus reverse tran-
scriptase, and 1 pmol of downstream primer D2 at 42°C for
60 min. This reaction mixture (1/20) was used for standard
PCR amplification with primers Dl (5'CACATI`TTCAAG
TGAAGACTTGAG3') and D2 (5'GGTCCTGGAATGCA
ACATCCT3'), which produces a fragment of 876 bp on
genomic DNA and of 486 bp on normally spliced RNA. The
positions of primers used in this study are diagrammed in
Fig. 1B. Primer D3 (5'GCGGAATTCATGAGAATAACTA
CGAGA3') was used to determine whether exon skipping
was occurring in e128 RNA.
To determine whether the most slowly migrating band in
Fig. 4, lane 5, represents a heteroduplex, the two lower
bands were cut out of gels, mixed, heated to 95°C for 5 min,
and then slowly cooled. Gel electrophoresis of this mixture
revealed three bands, the two original bands as well as the
third, more slowly migrating species. In addition, the slow-
est band was excised from a gel, heated to 95°C for 5 min,
and then slowly cooled. Gel electrophoresis of this sample
resulted in the same three bands.
Sequencing of transcripts. (i) ket-23(nl045) and let-23
(sy97sy122). Reverse-transcribed n1045 and wild-type RNA
were PCR amplified with exon 16 and exon 18 primers. The
single band produced by wild-type RNA and the three visible
bands produced by n1045 RNA were subcloned into pBlue-
script SK+. Individual colonies were picked, miniprepped,
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and cut with restriction enzymes to verify insert and size.
Most minipreps were sequenced by using a primer from exon
17 (extending toward exon 16) starting at approximately 100
bases from the start of exon 17. Sequencing was performed
by using standard double-stranded sequencing reactions and
Sequenase version 2.0. Only one strand was sequenced.
Point mutations were not detected as a result of PCR
amplification. Some subclones, including those lacking exon
17, were sequenced by using vector primers. The wild-type-
size band in sy97syl22 was similarly subcloned. Sequencing
was performed by using a primer from exon 18. One of the
subclones (described in the text) was over 100 nt shorter
than the rest, evidently being a contaminant in the gel-
excised wild-type-size band.
(ii) dpy-1O(el28). Reverse transcription-PCR products gen-
erated by using primers Dl and D2 were cut with SalI and
SacI restriction enzymes, which cut just internal to these
primers, yielding a 176-bp fragment (when normal splicing
occurs). These fragments were cloned into pBS cut with SalI
and Sac. Clones that contained approximately correctly
sized inserts were selected as assayed by restriction analyses
and were sequenced by using standard double-stranded
dideoxy sequencing with Sequenase version 2.0 and a uni-
versal sequencing primer.
Quantitation of RNA. (i) let-23(nl045). Quantitation of the
relative abundance of the four nlO45 transcript species was
carried out as follows. 32P-end-labeled primers were used to
amplify n1045 cDNA, as described above, for 15, 20, 22, and
25 rounds. The reactions were electrophoresed on a 5%
denaturing acrylamide gel. No products were visible at 15
rounds (data not shown). The relative intensities of all four
n1O45 bands in each lane were determined by using a
PhosphorImager (400S; Molecular Dynamics, Sunnyvale,
Calif.). The ratios of the three lower bands to each other in
each lane did not vary significantly at 20, 22, and 25 rounds
of amplification, suggesting that amplification was not at
saturation. Since we are quantitating the ratios of the bands
within a given lane, the ratios are internally controlled
except for the relative efficiencies of amplification. Since the
three lower bands are small and similar in size (264, 372, and
425 bases), we do not expect much error due to inefficiencies
in amplification. The relative ratios of the upper band to the
others did not vary at 22 or 25 rounds but did vary at 20
rounds, probably because it was the weakest band or be-
cause it is much larger (741 bases).
Since one of the bands seen in the autoradiogram was the
same size as that expected for genomic DNA, we DNase
treated the RNA to determine whether this band was DNA
dependent. Sixty micrograms of nlO45 20°C RNA was
treated with 6 U of DNase (Promega) in the presence of 100
U of RNAsin (Promega) and buffer (final concentration: 40
mM Tris 7.5, 10 mM NaCl, 6 mM MgCl2, 1 mM dithiothre-
itol) in a total volume of 100 ,ul. The reaction mixture was
incubated at 37°C for 1 h, phenol-chloroform and chloroform
extracted, and then precipitated with ammonium acetate.
After reverse transcription and PCR amplification with la-
beled primers, the genomic-size band was still present (data
not shown), indicating that this band probably results from
lack of splicing at introns 16 and 17 and not from DNA
contamination.
RNase protection experiments were performed by using a
standard protocol (37). The subclone pIS8A was cut with
BamHI and transcribed with T7 RNA polymerase in the
presence of [a-32P]UTP. The resulting antisense transcript of
385 nt protects 130 nt of let-23 exon 6. The subclone pIS34
was cut withAccI and transcribed with T3 RNA polymerase.
This 140-nt antisense transcript protects 100 nt of let-23 exon
15, just upstream of the tyrosine kinase domain. Both these
probes should be common to all let-23(n1045) transcripts.
The subclone pT7/T3-18-103 (courtesy of M. Krause) was
cut with EcoRI and transcribed with T3 polymerase. This
250-nt antisense transcript protects 214 nt of the 3' untrans-
lated region of the actin gene act-i. The actin probe was
transcribed at one-third the specific activity of the let-23
probes. All probes were gel purified prior to hybridization.
For the two let-23 probes, 5 x 109 radiolabeled probes were
hybridized to approximately 20 p,g of n1045 or wild-type
total RNA. For the actin probe, 6 x 109 radiolabeled probes
were hybridized to 2 ,ug of n1O45 or wild-type total RNA.
Controls were carried out for each probe with yeast tRNA
(30 ,ug) in place of C elegans RNA. The remainder of the
protocol was carried out as described by Miner and Wold
(37) with RNases Ti and A. The PhosphorImager counts
detected in each protected band for let-23 RNA, wild-type
RNA, and tRNA, respectively, were 3.4 x 107, 7.2 x 107,
and 5.3 x 105 with the actin probe; 3.6 x 106, 3.2 x 106, and
3.4 x 105 with the pIS8A probe; and 3.9 x 106, 2.8 x 106,
and 3.4 x 105 with the pIS34 probe. After subtracting out
noise (tRNA lanes) and normalizing for the actin probe, the
pIS8A and pIS34 protections, respectively, suggest that
let-23 transcript levels in let-23(nlO45) are elevated to 2.4
and 3.2 times the levels in the wild type.
(ii) dpy-1O(el28). To determine levels of dpy-10 message in
e128 RNA, competitive quantitative PCR was used (18, 19).
This method used a known amount of competitive template
which is coamplified in PCR along with the unknown quan-
tity of cDNA from reverse-transcribed e128 RNA. The
competitive template used was a genomic DNA clone of the
dpy-10 gene, pAL5. Parallel samples, each containing 30 ng
of reverse-transcribed e128 RNA and serially diluted
amounts of pAL5 (ranging from 0.01 to 1.00 amol), were
amplified by using D4 (5'-GATCTACCGGTGTGTCAC-3')
and D2. Amplification with D4 and D2 of unspliced mRNA
or genomic DNA yields a 268-bp fragment; amplification of
spliced mRNA yields a 220-bp fragment. At the point where
the cDNA and genomic DNA templates are amplified
equally, the starting concentration of cDNA equals the
concentration of the pAL5 template. However, since some
of the dpy-10 transcripts are unspliced for intron 2, these
transcripts yield a product that is the same size as the
competitor, making it difficult to measure this point of equal
intensity; also, for this reason, the amplified signal of the
e128 RNA-cDNA is always lower than that of the wild type.
We therefore took as the measure of equal concentrations
the point at which the concentration of competitor DNA
decreased the original RNA (cDNA) signal to one-half of its
value with no competitor added. PCRs were carried out with
1.0 ,ul of [a-32P]dATP (>400 Ci/mmol), and the radioactivity
in each band was then quantified with a Fujix BAS2000
Bio-Image Analyzer which determines radioactivity in units
of phospho-stimulable luminescence. The same procedure
was done with wild-type RNA. To control for differences in
RNA preparations, the same competition was performed
with the two RNAs by using sqt-l-specific primers. The sqt-1
gene is a cuticle collagen, which is similar in structure to
dpy-10 (33). Its expression is presumably not affected by
mutations in dpy-10.
RESULTS
let-23(nlO45) and dpy-1O(el28) 3' splice site mutations. The
product of the C. elegans gene let-23 is similar in primary
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FIG. 1. (A) Location of let-23(n1O45) point mutation. The exon-intron structure of the C terminus of the let-23 gene is shown. There are
18 exons in let-23, but only the portion from part of the way through exon 15 to the 3' untranslated region is shown. The gene extends for
over 7 kb upstream of the region shown. The kinase domain is just 5' to the region shown. Exons are shown as boxes; introns are shown as
solid lines between the boxes. The number in each box represents the exon number. The location of the n1045 mutation (G to A) in intron
16 is indicated above the schematic. Below the schematic, the sequence at and around the mutation is shown. Uppercase letters designate
the exon sequence, and lowercase letters designate the intron sequence. The locations of primers CTS5 and CTS3 used to analyze n1045
transcripts are indicated. (B) Location of dpy-1O(e128) mutation. The entire dpy-10 gene is diagrammed similarly to that for panel A. The
location of the e128 intronic mutation (AG to AA) is indicated above the schematic, as are the locations of the primers used to analyze the
e128 transcripts. Below the schematic, the sequence at and around the e128 mutation is shown. START and STOP refer, respectively, to the
locations of the start and stop of translation.
sequence to the mammalian epidermal growth factor recep-
tor (2). Genetic studies have shown that the let-23 receptor
tyrosine kinase is required for viability past the first larval
stage, for hermaphrodite fertility, and for the development of
the posterior ectoderm, the hermaphrodite vulva, and the
male spicules (3, 13). Elimination of let-23 activity results in
completely penetrant larval lethality (3).
The dpy-10 gene is structurally and functionally quite
different: dpy-10 encodes a cuticular collagen (35a) that is
similar in structure to the other sequenced cuticle collagens
(31-33, 60). Mutations in the dpy-10 collagen gene often
result in a dumpy phenotype such that the mutant nematodes
are shorter and fatter than the wild type (7). In addition,
mutations in the dpy-10 gene can sometimes result in a roller
phenotype-the nematodes roll while they move because of
a helical twist of the cuticle and underlying structures (11).
Elimination of the dpy-10 collagen gene results in nematodes
which are both dumpy and left-handed rollers (35a).
The let-23(nlO45) mutation was localized and sequenced
as part of a structure-function study of let-23 (2a). Many
alleles of let-23 have been isolated and genetically charac-
terized (3, 13, 14). The non-null, reduction-of-function allele
n1O45 is particularly interesting because it appears to be
defective in negative regulation of vulval development (3).
The n1045 allele was sequenced (see Materials and Meth-
ods), and it was found that the last base of intron 16 is altered
from G to A (Fig. 1A). This splicing mutation eliminates the
invariant AG at the 3' splice site.
A number of dpy-10 alleles, including dpy-1O(e128), were
also sequenced as part of a structure-function study. The
allele dpy-1O(e128) reduces but does not eliminate dpy-10
function. Sequencing of the e128 allele revealed that the last
nucleotide of intron 2 is altered from G to A (Fig. 1B), thus
changing the AG dinucleotide to AA. No other nucleotide
change is present within the dpy-10 gene.
Although the studies were carried out independently, we
are reporting the studies of let-23(nlO45) and dpy-1O(e128)
together to reinforce the results and conclusions with respect
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FIG. 2. Reverse transcription-PCR analysis of wild-type and nlO45 RNA. PCR amplification of wild-type and nlO45 reverse-transcribed
RNA was done with radiolabeled CTS5 and CTS3 primers. The products were electrophoresed on a 5% denaturing acrylamide gel, and the
gel was autoradiogrammed. Lanes: 1, 123-base ladder; 2, amplification of wild-type cDNA for 25 rounds; 3, negative PCR control (no
substrate). Amplification of n1045 cDNA was done for 25 (lane 4), 22 (lane 5), and 20 (lane 6) rounds. To the right, the sizes of the bands in
the n1045 lane, the percentages that each n1045 band represents relative to all the bands in the nl045 lane, the numbers of subclones from
each band sequenced, and the exon-intron structure of nlO45 transcripts found in each band are indicated (exon-intron structure is given as
shown in Fig. 1A). The exon-intron structure of the upper band is based on size only and not on sequence data. Seven subclones from the
wild-type band were also sequenced as a control. There is a faint extra band in the wild-type lane. Since it is not at the size predicted for any
splicing product, it could be caused by non-let-23-specific amplification. The weaker band immediately below the nl045 band at the size
expected for a wild-type splice is probably the result of cryptic splicing at the AG 17 bases downstream of the normal 3' splice site.
to splicing. The significance of these results with respect to
the function of the let-23 and dpy-10 genes will be discussed
separately (2a, 35a).
Splicing in ket-23(nl045). To ascertain the effect of the
nl045 mutation on let-23 mRNA, we isolated total RNA
from homozygous let-23(n1O45) hermaphrodites, reverse
transcribed the RNA by using random primers, and then
performed PCR amplification with primers from exon 16 and
the 3' untranslated region in exon 18. The results are shown
in Fig. 2. Amplification of reverse-transcribed RNA from
wild-type hermaphrodites yields only one band at the ex-
pected size of 372 nt (exon 16-exon 17-exon 18). However,
amplification of reverse-transcribed RNA from nl045 yields
four bands. Two of these bands are consistent in size with
the effects of 3' splice site mutations in other systems: exon
skipping (exon 16-exon 18) and a failure to splice (exon
16-intron 16-exon 17-exon 18). The other two bands are
unexpected: a prominent band at the size expected for a
wild-type splice (exon 16-exon 17-exon 18) and a fainter
band at the size expected for two unspliced introns (exon
16-intron 16-exon 17-intron 17-exon 18). The relative inten-
sities of these four bands were determined and represent,
respectively, 1.5% (the exon 16-intron 16-exon 17-intron
17-exon 18 band), 4.5% (the exon 16-intron 16-exon 17-exon
18 band), 52% (the exon 16-exon 17-exon 18-size band), and
42% (the exon 16-exon 18 band) of the total transcript
species in n1045.
Sequencing verified that the lower band at 264 nt con-
tained transcripts generated by exon skipping (exon 16-exon
18) and that the band at 425 nt, slightly above that of the wild
type, contained transcripts with unspliced intron 16 (exon
16-intron 16-exon 17-exon 18). The upper band at 741 nt was
not sequenced since it was too difficult to cut out of an
ethidium-stained gel. Nonetheless, the size is as predicted
for unspliced introns 16 and 17 (exon 16-intron 16-exon
17-intron 17-exon 18).
We were surprised at the results of sequencing 11 sub-
clones from the n1045 band at the size (372 nt) expected for
a wild-type splice (Fig. 3). In two subclones, a cryptic AG,
17 bases downstream of the mutated intron 16 3' splice site,
was used as a 3' splice site. However, in five subclones, a
splice had occurred where the splice occurs in the wild-type
despite the fact that there was an AA and not an AG 3'
acceptor. In the remaining four subclones, a cryptic AU (two
different ones), GG, and UG were used as the 3' splice site.
These four non-AG cryptic sites are all within 8 bases of the
normal 3' splice site. Despite the great variation of 3' splice
sites used, the normal 5' splice donor site of intron 16 was
J.
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FIG. 3. Splicing near the intron 16 3' splice site in let-23(nlO45). Eleven subclones from the n1O45 band at the size expected for a wild-type
splice product were sequenced. The splices inferred from that sequencing are shown. Lowercase letters denote the intron sequence;
uppercase letters denote the exon sequence. The larger downward-pointing arrowhead indicates the 5' junction used for all splices and is the
correct 5' splice site. The upward-pointing arrowheads indicate the 3' splice junctions used. The numbers beneath each arrowhead indicate
the number of subclasses in which a given 3' splice site was found.
used for all spliced transcripts. It is possible that we have not
identified all the transcripts found in let-23(nlO45) since
some of the splice products are represented by single sub-
clones.
As shown in Fig. 2, reverse transcription-PCR analysis of
wild-type RNA results in only one band at the expected size.
As a control, we sequenced seven subclones from this band.
All indicate a perfect splice from exon 16 to exon 17. Thus,
the unusual n1045 splicing products do not occur in the wild
type and are unlikely to be an artifact of PCR.
We performed several other controls (details in Materials
and Methods). First, the results are reverse transcriptase
dependent. Second, splicing of upstream introns occurs
normally. Third, none of the n1045 bands disappear upon
treatment of the RNA with DNase prior to reverse transcrip-
tion, indicating that the bands seen, in particular the un-
spliced exon 16-intron 16-exon 17-intron 17-exon 18 tran-
script, are the result of RNA and not DNA. Lastly, two
other independent nJO45 RNA preparations result in the
same bands after reverse transcription-PCR amplification.
We quantitated the abundance of let-23 message in the
n1045 mutant by RNase protection. We used two different
let-23 antisense probes that are common to all let-23 tran-
scripts and normalized to an actin antisense probe. The data
indicate that the combined level of all let-23 transcripts in the
n1045 mutant is elevated to approximately threefold that of
the single let-23 message in the wild type. This result was
verified with quantitative and competitive PCR experiments,
which indicate that relative to the rol-6 collagen gene, the
combined level of all let-23 messages in n1045 is elevated to
roughly four- to fivefold that of the single let-23 message in
the wild type (data not shown). A caveat to interpreting this
result is that the physiologies of the nlO45 and wild-type
strains might differ (e.g., there are many dead larvae asso-
ciated with nJO45). Nonetheless, we conclude that the
amount of let-23 transcript in n1045 is significant relative to
the amount of let-23 transcript in the wild type.
Splicing in dpy-1O(e128). To determine the splicing behav-
ior of the dpy-1O(eI28) mutant, reverse transcription and
PCR amplification were performed with RNA isolated from
e128 animals. The results are shown in Fig. 4. Amplification
of reverse-transcribed wild-type RNA results in a single
486-bp band, as expected for normal splicing of introns 1 and
2 (lane 4). Amplification of reverse-transcribed e128 RNA
results in three bands (lane 5). The predominant band,
representing about two-thirds of the total signal, appears at
the size of the normally spliced product. A larger, 534-bp
band appears at the size expected when intron 1 is normally
spliced but intron 2 is unspliced. We have determined that a
third band, which migrates more slowly than the other two
bands, is a heteroduplex consisting of one strand of un-
spliced product and one strand of spliced product. Examples
of such heteroduplexes have been previously reported (61,
64). To determine whether exon skipping was occurring,
primer D3 (Fig. 1B) was used for reverse transcription-PCR
analysis. No product that would suggest that exon 3 is
skipped in any e128 transcripts was detected (data not
shown).
The reverse transcription-PCR products in the apparently
normally spliced band at 486 bp were cloned, and 13 sub-
clones were sequenced. Three distinct 3' splice sites were
found to be used (Fig. 5). In two clones, splicing occurred at
the same location as in the wild type, despite the presence of
the AA dinucleotide; in four clones, splicing occurred at an
upstream AA acceptor at position -8 relative to the location
kb
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FIG. 4. Reverse transcription-PCR analysis of wild-type and
e128 RNA. PCR amplification for 30 rounds of wild-type and e128
reverse-transcribed RNA was done with primers Dl and D2 (see
Fig. 1B). Lanes: 1, +X174 marker cut with HaeIII; 2, amplification
of wild-type DNA; 3, amplification of dpy-1O(e128) DNA; 4, ampli-
fication of wild-type cDNA; 5, amplification of e128 cDNA. The
sizes of genomic DNA (876 bp of 5' untranslated exon 1-intron
1-exon 2-intron 2-exon 3), unexcised intron 2 (534 bp of 5' untrans-
lated exon 1-exon 2-intron 2-exon 3), and spliced RNA (486 bp of 5'
untranslated exon 1-exon 2-exon 3) are indicated on the right, as is
the spliced-unspliced heteroduplex (het) (see Materials and Meth-
ods).
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FIG. 5. Splicing near the intron 2 3' splice site in dpy-1O(e128). Thirteen subclones from the 486-nt e128 band (Fig. 4, lane 5) were
sequenced. The splices inferred from the sequencing are shown. The results are represented as described in the legend to Fig. 3.
of the wild-type 3' splice site; in the remaining seven,
splicing occurred at the AG that immediately follows the
mutated site, corresponding to position +2. As a control,
two wild-type dpy-10 cDNAs were sequenced and found to
splice at the expected 3' acceptor. Thus, consistent with the
results for let-23(nlO45), the splicing machinery can still
recognize and use the mutant splice site at least some of the
time despite the absence of the universally conserved AG
dinucleotide. Also surprising is the utilization of the acceptor
at -8 that also consists of an AA rather than an AG
dinucleotide.
To determine the level of dpy-10 transcripts in e128 RNA,
we performed quantitative, competitive PCR (see Materials
and Methods) (18, 19). We performed these experiments
with e128 and wild-type RNAs to determine whether a
difference in dpy-10 transcript levels could be detected. To
control for differences in the RNA preparations, competitive
PCR was also carried out with e128 and wild-type RNAs by
using primers from the sqt-1 collagen gene (33).
The results are shown in Fig. 6, in which we have charted
the decrease in the intensity of the amplified cDNA band
PSL
(ordinate) as increasing amounts of competitor DNA are
added (abscissa). The point at which the cDNA product
decreases to one-half of its maximum signal (with no com-
petitor added) represents the point at which the initial
concentrations of DNA competitor and cDNA are equal.
Figure 6A shows that the wild-type and e128 RNA prepara-
tions give nearly identical results when the sqt-I control
cDNA is amplified, indicating that the levels of sqt-1 in the
two RNAs are very similar. Thus, differences seen when the
dpy-10 cDNAs are amplified are probably not due to differ-
ences between the two RNA preparations. Figure 6B shows
the results of the dpy-10 competition. The point at which the
cDNA band decreases to one-half of its original signal is at
0.07 and 0.11 amol of competitor DNA for e128 and wild-
type RNA, respectively. We therefore estimate that the total
level of dpy-10 message in e128 RNA is 65% of that in the
wild type. Thus, as with let-23(nlO45), the unusual splicing
products seen are occurring at significant levels relative to
wild-type dpy-10 splicing products.
Splicing in let-23(sy97sy122). To determine whether our
results applied to longer C. elegans introns, we analyzed
PSL
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0.2 0.4 0.6 0.8 1 1.2
attomoles gDNA
0.12
1/2 competition
0.2 0.4 0.6
attomoles gDNA
0.8 1 1.2
e128 N2
0.07 0.11
1/2
competition
FIG. 6. Quantitation of dpy-10 transcript levels in wild type and dpy-1O(e128). Competitive quantitative PCR was performed as described
in the text. (A) Decrease in signal of sqt-1 control cDNA when increasing amounts of competitor DNA (a plasmid clone) are added to the PCR
mixture. The point at which the signal decreases to one-half of its maximum represents the point at which the initial concentrations of cDNA
and competitor are equivalent. (B) Results of dpy-10 quantitation with primers D4 and D2. The level of cDNA in e128 is lower at all points
than that of the wild type because a fraction of the dpy-10 cDNAs in e128 is unspliced and therefore runs at the same position as the
competitor. Nonetheless, the point at which one-half competition is reached is unaffected. The estimate of the amount of dpy-10 transcript
in the wild-type RNA is 0.11 amol, while in e128 RNA it is 0.07 amol. The competitor used is a plasmid clone containing the wild-type dpy-10
gene. Quantitation was performed by including a radiolabeled nucleotide in the PCR mix and the use of a phospho-imager. *, N2 RNA; *,
e128 RNA; PSL, phospho-stimulable luminescence.
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w.t. agAG
exon 17 intron 17 exon 18
...ACCGguuagcuucaa ...(274 nt)... aaaaaguuacuuuuaaauaauaaauuuucaa,AACUAUCCCCAUC...
FIG. 7. Splicing near the intron 17 3' splice site in let-23(sy97sy122). Ten subclones from the wild-type-size band were sequenced. The
splices inferred from the sequencing are shown. The results are represented as described in the legend to Fig. 3. The alteration from wild-type
(w.t.) AGAG to AAAA is indicated.
splicing in the double-mutant let-23(sy97sy122) in which the
AG at the end of intron 17 (316 nt) is mutated to an AA and
the AG at the start of exon 18 is mutated to an AA, i.e., the
intron 17-exon 18 boundary is mutated from AG/AG to
AA/AA (Fig. 7). For this double mutant, we see primarily
two products upon reverse transcription of RNA and PCR
amplification (data not shown): a major product at the size
expected for wild-type transcript and a minor band at the
size expected for unspliced message. We sequenced 10
subclones of the wild-type-size transcript and found that all
splice at the normal (now AA) 3' splice site (Fig. 7). When
the AG at the end of intron 17 alone is mutated to AA,
splicing occurs exclusively to the adjacent exonic AG (2a).
(See Discussion.) Thus, as with let-23(n1045) and dpy-
10(el28), an AA can be used as the 3' splice site in this long
intron. Unlike that in let-23(nlO45) and dpy-10(e128), only
this one splicing product was found in the wild-type-size
band. We find no evidence of splicing to the closest AG
upstream (25 nt away) or downstream (108 nt away) of the
normal intron 17 splice acceptor site.
Among the wild-type-size subclones, we did find a sub-
clone that was significantly shorter. In this let-23(sy97sy122)
transcript, the UUUCAG found just downstream of the
let-23 stop codon (2) is used as the 3' splice site. The
resulting transcript is 190 nt shorter than the wild type. Since
we do not see a strong band at this size upon amplification of
sy97sy122 cDNA, this transcript is probably a very minor
component of sy97syl22 transcripts. The analysis of PCR-
amplified-reverse-transcribed wild-type RNA provides no
indication that this site is used during wild-type splicing.
DISCUSSION
The results presented in this report indicate that the
dinucleotide AG found at the 3' end of virtually all eukary-
otic introns is not absolutely essential for proper splicing of
C. elegans introns and that non-AG 3' splice acceptor sites
can, in some circumstances, compete with AG 3' splice
sites. In both of the non-null mutations let-23(n1045) and
dpy-10(e128), the AG dinucleotides located at the 3' end of
short introns (53 and 48 nt, respectively) are mutated to AA.
For let-23(n1045), this mutation results in at least nine
transcripts, compared with one for the wild type. Of all the
transcripts, 52% result from six different transcripts splicing
at or near the 3' splice site of the wild-type intron 16, 42%
result from exon skipping (pairing of the 5' splice site of
intron 16 with the 3' splice site of intron 17), 4.5% result from
a failure to splice out intron 16, and 1.5% result from failure
to splice out both intron 16 and intron 17. For dpy-10(e128),
at least four transcript species are generated. Of all the
transcripts, 67% result from three different transcripts splic-
ing at or near the 3' splice site of the wild-type intron 2 and
33% result from a failure to splice out intron 2. RNA
quantitation indicates that the splicing events seen in both
n1045 and e128 are occurring at significant levels relative to
those of the wild type.
For both let-23(n1045) and dpy-10(e128), the 3' splicing
events seen at or near the mutated 3' splice site include
splicing to the mutated site (now AA), splicing to a nearby
cryptic AG (for e128, this AG is immediately adjacent to the
wild-type 3' splice site), and splicing to nearby cryptic sites
that are not AG (AA, AU, GG, and UG). These non-AG
sites conserve either the penultimate nucleotide (A) or the
ultimate nucleotide (G) of the wild-type 3' splice site (AG).
The nature and extent of unusual splicing seen in n1045
and e128 are virtually unprecedented. Although there are a
few examples in yeasts of correct splicing to a mutated 3'
splice site or of splicing to non-AG 3' splice sites (see
below), we know of no other case in which mutation of the
3' splice site led to such high levels of correct splicing at the
mutated 3' splice site or to such promiscuous splicing at
nearby non-AG sites. The extent of other splicing products
seen is also noteworthy.
We also analyzed splicing in the allele let-23(sy97sy122).
In this double mutant, the AG at the end of let-23 intron 17
(316 nt) and the AG at the start of exon 18 are both mutated
to AA. Splicing occurs exclusively at the AA at the end of
intron 17, indicating that an AG is also not required for
splicing of this longer intron.
Although our results are unusual, we note that the effects
of the point mutations on splicing were determined in vivo
and in the context of the entire gene. That the let-23 and
dpy-10 mutations are independently isolated and that the
genes let-23 and dpy-10 themselves are functionally unre-
lated suggests that our results are generalizable to other C.
elegans introns.
Splicing in C. elegans. Splicing in C. elegans shares many
features in common with splicing in other organisms (re-
viewed in reference 6). C. elegans genes with sequences
similar to the RNA components of the Ul, U2, U4/U6, and
U5 small nuclear ribonucleoproteins have been character-
ized and cloned previously (55, 56). On the basis of these
sequences, the C. elegans splicing machinery is likely to be
similar to that of other eukaryotes (6). Furthermore, the
splice acceptor AG is conserved, and the consensus se-
quence at the 5' splice donor site of C. elegans introns is the
same as that for vertebrates, including the invariant GU at
the 5' splice site (15).
However, C. elegans introns are unusually short-greater
than 64% are less than 75 nt, with a strong peak in the
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distribution at 45 to 55 nt (6, 15). In contrast, most introns of
other higher eukaryotes are 75 to 2,000 nt long, and efficient
splicing of these introns may require a minimal length of
approximately 80 nt (63). Hence, there may be elements of
the C. elegans splicing apparatus which differ from those of
higher eukaryotes to efficiently splice such a large percent-
age of small introns. Another invertebrate, Drosophila mel-
anogaster, also has short introns (24).
There are other unusual features of splicing in C. elegans.
Many C. elegans introns lack a potential branch point
sequence (pyrimidine-purine-A-pyrimidine or YRAY) such
as is found in higher organisms (6, 15). In addition, C.
elegans introns have a highly conserved 3' splice site:
UUUCAG, with a U present at -5 relative to the cleavage
site in over 98% of the introns (6, 15). Lastly, C. elegans
introns, like plant introns, have an elevated A-U content just
upstream of the 3' splice site that may be important for their
processing (5, 62). Conversely, just upstream of the 3' splice
site of higher eukaryotic introns is the polypyrimidine
stretch that is important for their splicing (44, 45, 48, 51).
To determine whether C. elegans introns may be spliced
differently from mammalian introns, the splicing of C. ele-
gans short introns (about 50 nt) was assayed in mouse cells
and HeLa cell extracts (29, 42). In neither case did correct
splicing occur. In only one of these two cases (42), correct
splicing was restored by lengthening the intron.
Intron 16 of let-23 and intron 2 of dpy-10 fit the above
profile of C. elegans introns. They are both short (53 and 48
nt, respectively), relatively A-U rich, and fit the 3' splice site
consensus sequence in five of six places. There are three
potential branch point sequences (YRAY) in intron 16 of
let-23 (located at -19, -28, and -43) and one in intron 2 of
dpy-10 (located at -11). The YRAY sequence in dpy-10 is
closer to the 3' splice site than is usual for a branch point
sequence.
Our in vivo results indicate that for these short C. elegans
introns, an AG is important, but not essential, for the first
step of splicing, i.e., cleavage at an upstream 5' splice site.
In both let-23(n1045) and dpy-10(e128) [the mutation let-
23(sy97sy122) is discussed below], mutation of the AG
results in some stable transcripts with an unspliced intron,
indicating that the AG does influence the efficiency of the
first step of splicing. However, we cannot exclude that this
effect is indirect, e.g., the mutation at the 3' splice site could
speed up the transport pathway. Nonetheless, splicing can
occur without the AG, and, when it does, the correct 5'
splice site is chosen. Thus, to the extent analyzed, the
downstream AG does not influence the accuracy of cleavage
at the 5' splice site.
Our results also indicate that for these introns AG is
important, but not essential, for the second step of splicing,
i.e., cleavage at the 3' splice site and exon ligation. In both
let-23(n1045) and dpy-10(e128), splicing to the correct site
occurs even though the splice acceptor was mutated from
AG to AA. From this, and other non-AG splices seen, we
can also conclude that an AG per se is not essential for
cleavage and ligation at the 3' splice junction, although our
data suggest that there must be a match to either the A or the
G. This preference for an A in the penultimate position or a
G in the ultimate position may reflect some base pairing
interaction with a small nuclear RNA (e.g., Ul) (20 [and
references therein]). Despite the unusual splices that still
occur when the AG is mutated, the data do indicate that an
appropriately placed AG is important for proper splicing
since in wild-type animals only the proper splice occurs.
A model for 3' splice site selection in short C. ekgans
introns. What then determines the pattern of promiscuous
splicing seen close to the wild-type 3' splice sites of introns
16 and 2, respectively, of let-23(n1045) and dpy-10(eI28)?
The C. elegans splicing machinery may derive intron-exon
border information based on the AU versus the GC content,
as has been proposed for splicing in plants (5, 62). In both the
wild type and the mutants, this information could position
the machinery in the proper vicinity of the 3' splice site.
Unlike the wild type, however, the site of subsequent
cleavage and ligation is not perfectly determined.
Analysis of the actual splices made (Table 1) suggests that
the exact location of the splices in the mutants may depend
on competition among several of the sequence elements
discussed above: (i) an AG (i.e., any AG), (ii) the remainder
of the C. elegans 3' splice site consensus (i.e., UUUC, with
the highly conserved U underlined), (iii) an A-U-rich region,
and (iv) a putative branch site sequence. For example, of the
splices made in dpy-10(e128), all are downstream of an
A-U-rich region. However, the non-AG splices made do
have a U at position -5, whereas the AG(+2) splice does
not. This contrasts with the wild-type case in which the
splice occurs at an AG with a U at -5. On the other hand,
the AG (+ 15) is not used, perhaps because it cannot compete
with the other AG (+2) and because there is neither a U at
-5 relative to this AG nor an A-U-rich region immediately
upstream. For e128, there is no obvious role of potential
branch point sequences in 3' splice selection. For let-
23(nlO45), the analysis is similar. In all cases but the GG(+4)
splice, a U exists at -5 relative to a non-AG splice.
Furthermore, there is no U at -5 relative to the splice at the
cryptic AG, and this splice is the only one not preceded by
an A-U-rich region. As with e128, it may be that the cryptic
AG can sometimes be ignored if other nearby dinucleotides
contain other sequence elements important for splicing.
Unlike all the splices made in the mutant, all four sequence
elements are present in the wild-type gene. The GG (+4)
splice is perhaps made without a U at -5 because, after AG,
GG might be the best dinucleotide at the 3' splice acceptor
site (12).
We hypothesize that once the machinery is positioned at
the 3' splice site, the location of cleavage and ligation is
determined by an AG, an upstream motif related to UIJUC,
the A-U-rich region itself, and, perhaps to a lesser extent,
the presence of a suitable branch point sequence. In the
wild-type let-23 and dpy-10 introns studied here, these
preferences all cooperate so that splicing occurs at the
proper position. When the normal AG is mutated, these
preferences allow other potential sites to compete with each
other for selection as the 3' splice site. Consistent with the
notion that the four elements noted together contribute to
delineate a 3' splice site, our data also indicate that no one
element alone is absolutely required for splicing. We cannot
discern any influence in the selection of the 3' splice sites by
adjacent exonic nucleotides, as has been suggested for yeast
cells (41).
The presence of unspliced intron in the mutants but not in
the wild type may indicate that in the mutants either a
critical, timely recognition of the 3' splice site did not occur
and these unspliced transcripts have escaped splicing alto-
gether or the timing of splicing machinery is significantly
slowed down and these unspliced transcripts have yet to be
spliced. The presence of significant levels of exon skipping in
n1045 suggests that the intron 17 3' splice site can efficiently
compete with the mutated intron 16 3' splice region for
splicing to the intron 16 5' splice donor site. Exon skipping
may not be occurring with e128 because the size of the intron
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TABLE 1. Characteristics of different 3' splice sites used in dpy-10(e128), let-23(n1045), and let-23(sy97sy122) transcripts
Mutation Dinucleotide at No. of times sited used/ Occurrence Adjacent upstream A-U .ih' BPdsplice (location)a Total no. analyzed of AG sequenceb A c PS
dpy-10(el28) AG (+2) 7/13 Yes UCAA Yes +
AA (-8) 4/13 No UUUC Yes
AA (0) 2/13 No CLUC Yes +
AG (+15) 0O13e Yes GACG No ++
let-23(nlO45) AA (0) 5/11 No Ul1UU Yes ++
AG (+17) 2/11 Yes GCAC No ++
UG (-8) 1/11 No AU1UU Yes ++
AU (-5) 1/11 No UIUGC Yes ++
AU (+2) 1/11 No UUAA Yes ++
GG (+4) 1/11 No AAAU Yes ++
AGf 4/4 Yes UIJUC Yes ++
let-23(sy97sy122) AA (0) 10/10 No UIJUC Yes + +
AG (+190) 1/19 Yes ULJUC No ++
a Dinucleotide at the 3' splice site used for various splices; in parentheses, the locations of the splice made relative to the location of the wild-type splice site
(-, upstream; +, downstream) are indicated.
b The sequence of the four bases upstream of the dinucleotides adjacent to the splice site. The consensus sequence in C. elegans is UUUC. The highly
conserved U is underlined.
c Yes indicates that the region upstream of the splice is A-U rich; no indicates that the region is not A-U rich.d + + indicates a well positioned branch point sequence (BPS) 18 to 40 nt upstream of the 3' cleavage site; + indicates a poorly positioned BPS; - indicates
no nearby BPS.
e This site has not been shown to be used. It is included here to emphasize that, although it is a physically well positioned AG, it competes poorly with the
two non-AG 3' splice sites.
f This splice is made when the 5' splice donor of intron 16 is paired with the 3' splice acceptor of intron 17.
g See Materials and Methods for isolation of this subclone.
that needs to be spliced out for exon skipping to occur is
longer than in n1O45 (799 versus 470 nt; the 3' acceptor at
intron 3 of e128 is UIICCAG).
3' Splice site selection in longer C. elegans introns. The
introns mutated in let-23(n1O45) and dpy-1O(e128) are atypi-
cally short for most eukaryotes. Our analysis of mutations in
the longer intron 17 (316 nt) of let-23 suggests that some, but
not all, of our results with the short introns are applicable to
long introns. The 3' splice site of intron 17 matches the
consensus in six of six places and YRAY sequences exist at
-14 and -40 (Table 1).
Mutation of the intron 17 3' splice acceptor from AG to
AA results in splicing exclusively to the adjacent exonic AG
(2a). Thus, in contrast to the results with dpy-1O(eI28), the
mutated AA cannot compete with an adjacent AG despite
the presence of an otherwise perfect consensus. Further-
more, in both this single mutant and the double mutant
sy97sy122, only one rather than several 3' splice sites is
utilized. Together these results suggest that the selection of
3' splice sites for longer C. elegans introns may be less
flexible and somewhat different from that for short introns.
Along these lines, it has been suggested that the informa-
tional contents of short and long C. elegans introns are
different (15).
Nonetheless, splicing in the double mutant sy97sy122
indicates that an AG is not required for splicing, even of a
long C elegans intron. Splicing occurs primarily at the
normal (now AA) 3' splice site despite the presence of an AG
25 nt upstream. Thus, as with short introns, elements other
than an AG can direct the splicing of long introns. Although
we have not quantitated RNA levels in sy97sy122, the fact
that most of the let-23 phenotypes are close to those of the
wild type in this mutant (27a) suggests that significant levels
of splicing to the normal site are occurring. The presence of
the splice at the UIUUCAG 190 nt downstream of the normal
site (Table 1) supports our model for 3' splice selection: to
splice at this site, seven other AGs, none of which have a
perfect consensus, must be passed over.
Implications for splicing in other organisms. Although our
results may be a consequence of some unique aspect of
splicing in C. elegans and therefore limited to C. elegans,
there is some precedent for our results in yeasts and possibly
mammals. Mutation of the AG at the 3' end of the yeast
Saccharomyces cerevisiae actin intron (AG to GG or AC)
results in low levels of in vitro and in vivo splicing at the
correct (but mutated) 3' splice site (16, 59). In the actin
intron of the yeast Kluyveromyces lactis, a GG can compete
with the normal AG as the 3' splice site (12). Furthermore, in
one study of human analbuminemia, although the AG at a 3'
splice site was mutated to a GG, very low levels of albumin
were still detected in the bloodstream, suggesting that trace
amounts of correctly spliced transcripts were made (47). In a
study of steroid 21-hydroxylase deficiency in humans, S1
nuclease analysis of RNA suggested that a mutation which
created a 3' splice site (AC to AG) resulted in three abnor-
mal, closely spaced splicing products that use AG and AC as
3' splice sites (26). It is also possible that results similar to
ours have been missed in the past. Some previous studies
have relied on S1 nuclease and/or gel analysis assays, which
may be less sensitive than sequencing of PCR-amplified
cDNAs. Thus, our results may not be unique to C. elegans.
As discussed above, our data also suggest that primary
sequences apart from the AG and branch point sequence
influence 3' splice site selection and that these primary
sequences may have an incremental effect on defining the
competitiveness of 3' splice sites. Consistent with our find-
ings, there is growing evidence that elements besides the AG
and branch point sequence (e.g., other primary sequences,
secondary structures, and 5' splice sites) may influence the
strength and selection of 3' splice sites (12, 40, 43, 44, 46,
63).
The presence of exon skipping (exon 16-exon 18) and the
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occasional inclusion of intron 17 (exon 16-intron 16-exon
17-intron 17-exon 18) in nlO45 RNAs suggest that the intron
16 mutation is affecting splicing of the downstream intron.
These results, especially the latter, are consistent with the
idea that splicing occurs in a unitary complex of multiple
introns (38) or that an early step of splicing is exon definition
(46). According to this latter model, the inefficient associa-
tion of the splicing machinery at the 3' splice site of intron 16
may affect the ability of the splicing apparatus to associate
with the 5' splice site of intron 17.
Finally, the findings of this study suggest a mechanism for
generating diversity in mRNA transcripts-competition
among many closely positioned 3' splice sites, some of
which may not be AG. There are two relevant studies along
these lines. One is mentioned above (26). In the other,
analyses of rat ax2,u globulin mRNAs suggest that transcript
diversity for this family of genes may be generated in part by
using closely positioned AGs and UGs as 3' splice sites (17).
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